CS8701093A2 - Method of new cycloalkano/1,2-b/-indolesulphoamides production - Google Patents
Method of new cycloalkano/1,2-b/-indolesulphoamides productionInfo
- Publication number
- CS8701093A2 CS8701093A2 CS871093A CS109387A CS8701093A2 CS 8701093 A2 CS8701093 A2 CS 8701093A2 CS 871093 A CS871093 A CS 871093A CS 109387 A CS109387 A CS 109387A CS 8701093 A2 CS8701093 A2 CS 8701093A2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- indolesulphoamides
- production
- cycloalkano
- new
- new cycloalkano
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/12—Radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/86—Carbazoles; Hydrogenated carbazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Indole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CS886891A CS276468B6 (cs) | 1986-02-21 | 1987-02-19 | Způsob výroby nových /fenylsulfonamidoalkyl/ /fenylsulfonamido/eykloalkano/l,2-b/indolů |
CS886892A CS276469B6 (cs) | 1986-02-21 | 1988-10-19 | Způsob výroby cykloalkanonsulfonamidů |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3605566 | 1986-02-21 | ||
DE19863631824 DE3631824A1 (de) | 1986-02-21 | 1986-09-19 | Cycloalkano(1.2-b)indol-sulfonamide |
Publications (2)
Publication Number | Publication Date |
---|---|
CS8701093A2 true CS8701093A2 (en) | 1990-11-14 |
CS275837B6 CS275837B6 (en) | 1992-03-18 |
Family
ID=25841196
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CS871093A CS275837B6 (en) | 1986-02-21 | 1987-02-19 | Method of production of new cycloalkan0-|1,2b¨-indole sulfonamides |
Country Status (19)
Country | Link |
---|---|
US (3) | US4827032A (cs) |
EP (1) | EP0242518B1 (cs) |
JP (1) | JPH075552B2 (cs) |
KR (2) | KR940007302B1 (cs) |
AU (1) | AU595855B2 (cs) |
CA (1) | CA1309414C (cs) |
CS (1) | CS275837B6 (cs) |
DE (2) | DE3631824A1 (cs) |
DK (1) | DK167009B1 (cs) |
ES (1) | ES2028801T3 (cs) |
FI (1) | FI86544C (cs) |
GR (1) | GR3001763T3 (cs) |
HU (1) | HU198686B (cs) |
IE (1) | IE59470B1 (cs) |
IL (1) | IL81611A (cs) |
NO (1) | NO171633C (cs) |
NZ (1) | NZ219319A (cs) |
PH (1) | PH24491A (cs) |
PT (1) | PT84316B (cs) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3826371A1 (de) * | 1988-08-03 | 1990-02-08 | Bayer Ag | Tetrahydro-1-benz-(c,d)-indolpropionsaeure-sulfonamide |
DE3829455A1 (de) * | 1988-08-31 | 1990-03-15 | Boehringer Mannheim Gmbh | Sulfonamidoalkyl-cyclohexan-verbindungen, verfahren zu ihrer herstellung sowie arzneimittel |
US4959383A (en) * | 1988-10-31 | 1990-09-25 | E. R. Squibb & Sons, Inc. | Phenylsulfone alkenoic acids, derivatives thereof, compositions containing same and method of use |
US5006542A (en) * | 1988-10-31 | 1991-04-09 | E. R. Squibb & Sons, Inc. | Arylthioalkylphenyl carboxylic acids, derivatives thereof, compositions containing same and method of use |
US5070099A (en) * | 1988-10-31 | 1991-12-03 | E. R. Squibb & Sons, Inc. | Arylthioalkylphenyl carboxylic acids, derivatives thereof, compositions containing same method of use |
GB8924392D0 (en) * | 1989-10-30 | 1989-12-20 | Bayer Ag | Substituted cycloalkano/b/dihydroindole-and-indolesulphonamides |
GB9008108D0 (en) * | 1990-04-10 | 1990-06-06 | Bayer Ag | Cycloalkano(b)dihydroindoles and-indolesulphonamides substituted by heterocycles |
DE4027278A1 (de) * | 1990-08-29 | 1992-03-05 | Bayer Ag | Heterocyclisch substituierte indolsulfonamide |
US5827871A (en) * | 1991-06-26 | 1998-10-27 | Smithkline Beecham Plc | Medicaments 1,2,3,4-tetrahydrocarbazoles and 5-HT1 agonist use thereof |
DE4131346A1 (de) * | 1991-09-20 | 1993-03-25 | Bayer Ag | Indolsulfonamid substituierte dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln |
ES2122982T3 (es) * | 1992-12-18 | 1999-01-01 | Smithkline Beecham Plc | Derivados de tetrahidrocarbazol para la fabricacion de un medicamento para el tratamiento de una enfermedad en la que esta indicado un agonista similar a 5-ht1. |
DE19507751A1 (de) * | 1995-03-06 | 1996-09-12 | Bayer Ag | Verfahren zur Herstellung von substituierten 1,2,3,4-Tetrahydrocarbazolen |
US5708187A (en) * | 1996-06-27 | 1998-01-13 | Eli Lilly And Company | 6-substituted-1,2,3,4-tetrahydro-9H-carbazoles and 7-substituted-10H-cyclohepta 7,6-B!indoles: New 5-HT1F agonists |
DE19757983A1 (de) * | 1997-12-24 | 1999-07-01 | Bayer Yakuhin Ltd | Thermodynamisch stabile Form von (r)-3[[(4-Fluorophenyl)sulfonyl]amino]-1,2,3,4-tetrahydro-9H-carbazol-0-propansäure (Ramatroban) |
JP4972644B2 (ja) * | 2005-08-12 | 2012-07-11 | メルク カナダ インコーポレイテッド | Crth2受容体拮抗薬としてのインドール誘導体 |
US7662831B2 (en) * | 2006-07-27 | 2010-02-16 | Wyeth Llc | Tetracyclic indoles as potassium channel modulators |
US7601856B2 (en) * | 2006-07-27 | 2009-10-13 | Wyeth | Benzofurans as potassium ion channel modulators |
WO2008017989A1 (en) | 2006-08-07 | 2008-02-14 | Actelion Pharmaceuticals Ltd | (3-amino-1,2,3,4-tetrahydro-9h-carbazol-9-yl)-acetic acid derivatives |
GB0624084D0 (en) * | 2006-12-01 | 2007-01-10 | Selamine Ltd | Ramipril amino acid salts |
GB0624087D0 (en) * | 2006-12-01 | 2007-01-10 | Selamine Ltd | Ramipril combination salt |
GB0624090D0 (en) * | 2006-12-01 | 2007-01-10 | Selamine Ltd | Ramipril amine salts |
WO2008075028A1 (en) * | 2006-12-20 | 2008-06-26 | Cardoz Ab | New combination for use in the treatment of inflammatory disorders |
US20100099693A1 (en) * | 2007-01-16 | 2010-04-22 | Johan Raud | New combination for use in the treatment of inflammatory disorders |
WO2009007674A2 (en) * | 2007-07-11 | 2009-01-15 | Cardoz Ab | Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and ramatroban or seratrodast |
WO2010008864A2 (en) * | 2008-06-24 | 2010-01-21 | Amira Pharmaceuticals, Inc. | Cycloalkane[b]indole angtagonists of prostaglandin d2 receptors |
EP2307382B1 (en) * | 2008-07-15 | 2011-12-21 | F. Hoffmann-La Roche AG | Aminotetrahydroindazoloacetic acids |
US8124629B2 (en) | 2008-11-17 | 2012-02-28 | Hoffmann-La Roche Inc. | Naphthylacetic acids |
EP2358677B1 (en) | 2008-11-17 | 2014-01-08 | F. Hoffmann-La Roche AG | Naphthylacetic acids used as crth2 antagonists or partial agonists |
RS52809B (en) | 2008-11-17 | 2013-10-31 | F. Hoffmann-La Roche Ag. | NAPHTHYL ACID |
HRP20141208T1 (hr) | 2010-03-22 | 2015-02-13 | Actelion Pharmaceuticals Ltd. | Derivati 3-(heteroaril-amino)-1,2,3,4-tetrahidro-9h-karbazola i njihova uporaba kao modulatora receptora prostaglandina d2 |
RU2596823C2 (ru) | 2011-04-14 | 2016-09-10 | Актелион Фармасьютиклз Лтд | ПРОИЗВОДНЫЕ 7-(ГЕТЕРОАРИЛ-АМИНО)-6,7,8,9-ТЕТРАГИДРОПИРИДО[1,2-a]ИНДОЛ-УКСУСНОЙ КИСЛОТЫ И ИХ ПРИМЕНЕНИЕ В КАЧЕСТВЕ МОДУЛЯТОРОВ РЕЦЕПТОРА ПРОСТАГЛАНДИНА D2 |
US8470884B2 (en) | 2011-11-09 | 2013-06-25 | Hoffmann-La Roche Inc. | Alkenyl naphthylacetic acids |
MY179356A (en) | 2014-03-17 | 2020-11-05 | Idorsia Pharmaceuticals Ltd | Azaindole acetic acid derivatives and their use as prostaglandin d2 receptor modulators |
KR20160133536A (ko) | 2014-03-18 | 2016-11-22 | 액테리온 파마슈티칼 리미티드 | 아자인돌 아세트산 유도체 및 프로스타글란딘 d2 수용체 조절제로서의 이의 용도 |
US20180021302A1 (en) | 2015-02-13 | 2018-01-25 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Ptgdr-1 and/or ptgdr-2 antagonists for preventing and/or treating systemic lupus erythematosus |
PL3350179T3 (pl) | 2015-09-15 | 2021-08-02 | Idorsia Pharmaceuticals Ltd | Krystaliczne postacie |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1415322A (fr) * | 1963-12-09 | 1965-10-22 | Eastman Kodak Co | Nouveaux composés de 3-sulfamidocyclobutanone et de 3-sulfamidocyclobutanol |
US3642816A (en) * | 1967-08-10 | 1972-02-15 | Sterling Drug Inc | 3-acetamido-1 2 3 4-tetrahydrocarbazole |
JPS4713658Y1 (cs) * | 1969-12-18 | 1972-05-18 | ||
CH586678A5 (cs) * | 1970-05-25 | 1977-04-15 | Hoffmann La Roche | |
DE2226702A1 (de) * | 1972-05-25 | 1973-12-13 | Schering Ag | Neue mittel zur behandlung des diabetes mellitus |
JPS5186117A (en) * | 1975-01-27 | 1976-07-28 | Tanabe Seiyaku Co | Johoseibiryushiseizainoseiho |
US4235901A (en) * | 1978-05-08 | 1980-11-25 | American Home Products Corporation | 1-Hydroxyalkanamine pyrano(3,4-b)indole compositions and use thereof |
-
1986
- 1986-09-19 DE DE19863631824 patent/DE3631824A1/de not_active Withdrawn
-
1987
- 1987-02-04 NO NO870437A patent/NO171633C/no unknown
- 1987-02-11 DE DE8787101901T patent/DE3769191D1/de not_active Expired - Lifetime
- 1987-02-11 ES ES198787101901T patent/ES2028801T3/es not_active Expired - Lifetime
- 1987-02-11 EP EP87101901A patent/EP0242518B1/de not_active Expired - Lifetime
- 1987-02-13 AU AU68808/87A patent/AU595855B2/en not_active Expired
- 1987-02-18 NZ NZ219319A patent/NZ219319A/en unknown
- 1987-02-18 IL IL81611A patent/IL81611A/xx not_active IP Right Cessation
- 1987-02-19 FI FI870693A patent/FI86544C/fi not_active IP Right Cessation
- 1987-02-19 CA CA000530077A patent/CA1309414C/en not_active Expired - Lifetime
- 1987-02-19 PH PH34883A patent/PH24491A/en unknown
- 1987-02-19 CS CS871093A patent/CS275837B6/cs unknown
- 1987-02-19 PT PT84316A patent/PT84316B/pt not_active IP Right Cessation
- 1987-02-19 HU HU87650A patent/HU198686B/hu unknown
- 1987-02-20 IE IE43987A patent/IE59470B1/en not_active IP Right Cessation
- 1987-02-20 DK DK087187A patent/DK167009B1/da not_active IP Right Cessation
- 1987-02-20 KR KR1019870001410A patent/KR940007302B1/ko not_active Expired - Lifetime
- 1987-07-31 KR KR87008383A patent/KR960001914B1/ko not_active Expired - Fee Related
-
1988
- 1988-06-29 US US07/212,840 patent/US4827032A/en not_active Expired - Lifetime
-
1989
- 1989-02-08 US US07/308,152 patent/US4904797A/en not_active Expired - Lifetime
- 1989-11-28 US US07/442,043 patent/US4965258A/en not_active Expired - Lifetime
-
1991
- 1991-04-11 GR GR91400361T patent/GR3001763T3/el unknown
-
1992
- 1992-02-27 JP JP4076232A patent/JPH075552B2/ja not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CS8701093A2 (en) | Method of new cycloalkano/1,2-b/-indolesulphoamides production | |
PL275555A1 (en) | Method of manufacture of tetrahydro- furo-thieno /2,3-c/-pyridines | |
PL263736A1 (en) | A method of new tieno-1,4-diazepines production | |
PL266392A1 (en) | Method of obtaining novel 4-methyl-6-methylsulfinyl-4h-thiono/3,2-b/pyridone-7 | |
PL266932A1 (en) | The method of manufacture of new 1,4-benzodiasepine | |
PL266231A1 (en) | The method of manufacture of new derivatives of dilnidropyridine | |
CS567989A2 (en) | Method of substituted 1,3,5-triazintriones production | |
CS597887A2 (en) | Method of new lensofuran-2 ylimidazol derivatives production | |
HUT48571A (en) | Process for production of substituated 3,5-dichlor-2,4-difluor-benzol | |
CS960486A2 (en) | Method of pregnale-21-acid's 16,17-acetal-substituted derivatives production | |
CS850787A2 (en) | Method of substituted 1-phenoxy-3-amino-2-propanols production | |
CS292087A2 (en) | Method of ergolen derivatives production | |
CS415888A2 (en) | Method of new acylderivatives production | |
CS1009187A2 (en) | Method of new aminoalkanoyl-dibenzo (d,g) (1,3,6) dioxazocines production | |
CS548787A2 (en) | Method of new tetrahydrobenzothiazolo-quinolines production | |
CS686987A2 (en) | Method of new 1-aryloxy-dihydrobenzothiadiazinyl alkylamino-alkanes production | |
GB8729133D0 (en) | Method for production of 1-valine | |
CS105389A2 (en) | Method of 4-benzyloxy-3-pyrroline-2-on-1-yl-acetamide production | |
HUT48280A (en) | Process for production of starch-2,3,/dihydroxi-prophile/-ether | |
CS261652B3 (en) | Method of 2,2-dialkoxy propane production | |
PL263015A1 (en) | The method of manufacture of derivatives of 6-h-indol/2,3-b/-quinoline | |
CS719288A1 (en) | Method of 2,3-difluoro-6-nitrophenol production | |
CS112688A1 (en) | Method of 0,0-dimethyl-o-/3-methyl-4-nitrophenyl-phosphorothionate production | |
CS399788A1 (en) | Method of 9,10-antraquinone production | |
RO103087B1 (en) | Production method of 2, 4 diamino-6-(2-diethylphosphonoethyl)-s- |